Skip to Main Content

Paper Details

MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.
J Clin Invest
26
2021
AKT, AR, Androgen, Androgen receptor, CRPC, GATA2, GATA2 protein, MAPK, MAPK4, PCa, PCa cell, Prostate cancer, androgen, androgen receptor, cancer, castration-resistant PCa, human, men, prostate cancer, tumor
Author NameAffiliation
Ilsa ColemanFred Hutchinson Cancer Research Center
Chad J Creighton
Chad J CreightonDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
Peter S NelsonFred Hutchinson Cancer Research Center
Peter S NelsonUniversity of Washington
  • 1 - 7

Datasets

Release 1.2